ABVC BIOPHARMA INC (ABVC)

US00091F3047 - Common Stock

1  +0.04 (+4.5%)

After market: 1 0 (0%)

ABVC BIOPHARMA INC

NASDAQ:ABVC (9/27/2023, 7:09:48 PM)

After market: 1 0 (0%)

1

+0.04 (+4.5%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)11-13 2023-11-13/amc
Ins OwnersN/A
Inst Owners14.89%
Market Cap3.95M
Shares3.95M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts43.33
IPO11-09 2004-11-09
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABVC Daily chart

Company Profile

ABVC Biopharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Fremont, California and currently employs 19 full-time employees. The company went IPO on 2004-11-09. ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of drugs and medical devices derived from plants. The firm develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. The company has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, ABV-1703 and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). The company is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). The company has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1702 is used to treat myelodysplastic syndrome (MDS). ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. Its ABV-1519 is used for the treatment of non-small cell lung cancer.

Company Info

ABVC BIOPHARMA INC

44370 Old Warm Springs Blvd

Fremont CALIFORNIA

P: 15106680881.0

CEO: Howard Doong

Employees: 19

Website: https://abvcpharma.com/

ABVC News

News Image5 days ago - ChartmillFriday's session: top gainers and losers

What's going on in today's session

News Image9 days ago - ChartmillWondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

News Imagea month ago - ABVC BioPharma, Inc.ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study

FREMONT, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire  – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical...

News Imagea month ago - NewMediaWireABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Imagea month ago - NewMediaWireABVC Executes Cooperation Agreement for Strategic Investments

FREMONT, CA - (NewMediaWire) - August 17, 2023 -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agreement to exchange a 20% ownership stake in real estate property of Zhonghui United Technology (Chengdu) Group Co., Ltd. (“中汇联和科技(成都)集团有限公司”) and its affiliated enterprises (“Zhonghui”).

News Imagea month ago - ABVC BioPharma, Inc.ABVC Executes Cooperation Agreement for Strategic Investments

FREMONT, CA, Aug. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical...

ABVC Twits

Here you can normally see the latest stock twits on ABVC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example